ICD-10-CM Billable Code

A32.0

Cutaneous listeriosis

Clinical Classification Guidelines

Medical Intelligence & Overview

Cutaneous listeriosis is a rare form of infection caused by the bacterium Listeria monocytogenes, primarily affecting the skin. Although listeriosis more commonly involves the gastrointestinal system or nervous system, the cutaneous form presents with specific skin signs and symptoms. Recognizing this condition is important for diagnosis and management, especially in individuals with compromised immune systems.

Causes & Symptoms

Clinical Causes: Infection with Listeria monocytogenes, which can be transmitted through contaminated food products such as unpasteurized dairy, processed meats, and certain vegetables. Direct contact with contaminated surfaces or substances containing the bacteria. In immunocompromised individuals, such as those with HIV/AIDS, pregnant women, or cancer patients, the risk of developing atypical presentations like skin infections increases.

Key Symptoms: Localized skin lesions that may appear as erythematous (red) patches or nodules. Presence of ulcers or pustules on the skin surface. Swelling, tenderness, or warmth around the affected areas. In some cases, systemic symptoms like fever, chills, or malaise may accompany skin manifestations. Lesions may develop rapidly and can be mistaken for other skin infections or inflammatory conditions.

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves a combination of clinical evaluation and laboratory tests. A healthcare professional may perform skin biopsies or swabs from the lesion for microbiological culture to identify Listeria monocytogenes. Blood tests might be used to assess for systemic involvement. Imaging studies are rarely necessary but can be helpful if deeper tissue infection is suspected. Since cutaneous listeriosis is uncommon, it requires a high index of suspicion, especially in at-risk populations.

Treatment Protocols: Treatment typically involves antibiotics effective against Listeria monocytogenes, such as ampicillin or penicillin. Depending on the severity and extent of the infection, additional supportive measures might include wound care and monitoring for systemic symptoms. Management often requires coordination between infectious disease specialists and primary care providers to ensure comprehensive care. Early detection and appropriate therapy are key to preventing complications.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is A32.0 a billable ICD-10 code?
Yes, A32.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report A32.0?
Clinical documentation must specify the nature of Cutaneous listeriosis and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

cutaneous listeriosis